Cardiovascular Revascularization Medicine
Volume 11, Issue 3 , Pages 159-162 , July 2010

Early and late outcomes of clopidogrel and Coumadin combination for patients on oral anticoagulants undergoing coronary stenting

Received 18 February 2009 ,Revised 4 May 2009 ,Accepted 5 May 2009.

References 

  1. Steinhubl SR, Berger PB, Mann JT, et al. for the CREDO investigators Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2420
  2. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewi Nataraja Malmberg K, Rupprecht H, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358(9281):527–533
  3. Orford JL, Fasseas P, Burger K, Steinhubl SR, Holmes DR, Burger PB. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J. 2004;147:463–467
  4. Rubolli A, Colletta M, Sangiorgio P, Pasqual G. Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting; safety and efficacy data from a single center. Ital Heart J. 2004;5:919–925
  5. Van De Werf F, et al. Guidelines for management of patient with acute myocardial infarction presenting with ST segment elevation. Eur Soc Cardiol. 2003;24:28–66
  6. Bassand JP, et al. Guidelines for the diagnosis and treatment of non ST segment elevation acute coronary syndromes. European Society of Cardiology. Eur Heart J. 2007;161:1093–1110
  7. Rao AK, Pratt C, Berke A, et al. Thrombolysis In Myocardial Infarction (TIMI) trial—phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol. 1988;11:1
  8. Gage BF, Waterman AD, Shannon W, et al. Validation clinical classification schemes for predicting stroke: results from National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–2870
  9. Karjalainen PP, et al. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J. 2007;28:726–732
  10. Wang TY, et al. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry. Am Heart J. 2008;155:361–368
  11. Connally S, Pague J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–1912
  12. Ruiz Nodar JM, et al. Anticoagulant and antiplatelet therapy in 264 patients with atrial fibrillation undergoing coronary intervention and stent implantation. JACC. 2008;51-8:818–825
  13. Karjalainen PP, Vikmann S, et al. Safety of coronary percutaneous intervention during uninterrupted oral anticoagulant. Eur Heart J. 2008;29:1001–1010

PII: S1553-8389(09)00197-3

doi: 10.1016/j.carrev.2009.05.002

Cardiovascular Revascularization Medicine
Volume 11, Issue 3 , Pages 159-162 , July 2010

Article Tools

* Image Usage & Resolution